# Antipsoriatics Market - Key Players, Growth and Opportunities 2030 | Credence Research **The latest market report published by Credence Research, Inc. “Global Antipsoriatics Market: Growth, Future Prospects, and Competitive Analysis, 2023 – 2030.** The global Antipsoriatics Market has been steadily growing in recent years and is predicted to grow at a **8.20% CAGR between 2023 and 2030.** The market is anticipated to be worth **USD XX million by 2030**, up from **USD XX million in 2022.** Antipsoriatics are a class of medications and treatments specifically designed to manage and alleviate the symptoms of psoriasis, a chronic autoimmune skin condition characterized by the rapid buildup of skin cells, leading to the formation of red, scaly patches on the skin. Psoriasis is considered an inflammatory disorder, and antipsoriatic treatments primarily aim to reduce inflammation, slow down the growth of skin cells, and provide relief from the discomfort and aesthetic concerns associated with the condition. The antipsoriatics market refers to the pharmaceutical sector that specializes in the development, production, and distribution of medications and treatments designed to manage and alleviate the symptoms of psoriasis, a chronic autoimmune skin condition. Psoriasis is characterized by the rapid buildup of skin cells, resulting in red, scaly patches and plaques that can be both uncomfortable and cosmetically distressing. The condition affects millions of people worldwide, making the antipsoriatics market a significant and growing segment of the healthcare industry. **There are several types of antipsoriatic treatments, and they can be broadly categorized into topical, systemic, Technological Advancements and phototherapy approaches:** Topical Antipsoriatics: These are applied directly to the affected skin areas and are typically the first line of treatment for mild to moderate psoriasis. Common topical medications include corticosteroids, vitamin D analogs, tar preparations, and calcineurin inhibitors. They work by reducing inflammation and slowing down the production of skin cells in the affected areas. Systemic Antipsoriatics: When psoriasis is more severe or widespread, or when topical treatments are ineffective, systemic medications may be prescribed. These drugs work throughout the entire body and can be taken orally or by injection. Examples of systemic antipsoriatics include methotrexate, cyclosporine, and various biologic agents such as TNF-alpha inhibitors and IL-17 inhibitors. These drugs target the underlying immune system dysfunction that contributes to psoriasis. Phototherapy: This involves exposing the skin to ultraviolet (UV) light under controlled conditions. Phototherapy can be administered in a medical setting or at home with specialized equipment. UVB (ultraviolet B) and PUVA (psoralen plus ultraviolet A) are two common types of phototherapy used to treat psoriasis. The UV light helps to slow down skin cell growth and reduce inflammation. Technological Advancements: Advances in pharmaceutical research and development, including biotechnology and genomics, continue to drive innovation in the antipsoriatics market. These innovations aim to provide more targeted and effective treatments with fewer side effects. **The growth factors for the antipsoriatics market worldwide can be attributed to several key factors:** Increasing Prevalence of Psoriasis: The rising prevalence of psoriasis, a chronic skin condition, is a significant driver for the antipsoriatics market. As the number of individuals affected by psoriasis continues to grow globally, the demand for effective treatments also increases. Advancements in Treatment Options: Advances in research and development have led to the introduction of novel treatment options for psoriasis. Biologic drugs, targeted therapies, and topical treatments have expanded the range of choices available to patients, driving market growth. Rising Awareness: Increased awareness about psoriasis and its impact on patients' quality of life has prompted more individuals to seek treatment. Public awareness campaigns and educational efforts have played a crucial role in driving demand for antipsoriatic drugs. Aging Population: The aging population is more susceptible to psoriasis, as it often develops or worsens with age. As the global population continues to age, the demand for antipsoriatics is expected to rise. **The global Antipsoriatics Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:** • Pfizer Inc. • AbbVie Inc. • Novartis AG • Evelo Biosciences, Inc • Amgen Inc. • Eli Lilly and Company • Evelo Biosciences, Inc. • LEO Pharma A/S • Merck & Co., Inc. • Johnson & Johnson Services, Inc. **Browse 247 pages report Antipsoriatics Market By Treatment Type (Topical Agents, Systemic Agents) By Biologics (TNF Inhibitors, IL Inhibitors, Topical Corticosteroids) By Patient Age Group (Adults, Pediatrics) – Growth, Future Prospects & Competitive Analysis, 2023 – 2030 - https://www.credenceresearch.com/report/antipsoriatics-market** **The antipsoriatics market can be analyzed regionally to understand the trends and dynamics specific to different geographical areas. Here's a regional analysis of the antipsoriatics market: North America:** • The North American antipsoriatics market is expected to remain a significant contributor to global revenue. The United States and Canada have a large patient population suffering from psoriasis. • The presence of key pharmaceutical companies and advanced healthcare infrastructure in this region drives research and development efforts for new antipsoriatic drugs. • Biologics and topical treatments are popular choices among healthcare providers and patients. **Europe:** • Europe is another prominent market for antipsoriatics, with countries like Germany, the United Kingdom, and France at the forefront. • Stringent regulatory standards ensure the safety and efficacy of antipsoriatic medications, driving the adoption of novel therapies. • Biologics have gained substantial market share due to their effectiveness, but traditional treatments such as topical steroids still play a significant role. **Asia-Pacific:** • The Asia-Pacific region is witnessing a growing prevalence of psoriasis due to changing lifestyles and environmental factors. • Increasing healthcare awareness, improving access to healthcare, and rising disposable incomes are driving market growth in countries like China and India. • Cost-effective generic versions of antipsoriatic drugs are prevalent in this region. **Latin America:** • Latin America represents an emerging market for antipsoriatics, with countries like Brazil and Mexico showing significant potential. • Economic development and expanding healthcare infrastructure are contributing to market growth. • Biologics may face affordability challenges in some countries, leading to apreference for conventional treatments. **Why to Buy This Report-** • The report provides a qualitative as well as quantitative analysis of the global Antipsoriatics Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028. • The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels. • Major nations in each region with their import/export statistics • The global Antipsoriatics Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major players analysis, market growth strategies, and key application areas. **Browse Complete Report- https://www.credenceresearch.com/report/antipsoriatics-market Visit our Website- https://www.credenceresearch.com Related Reports- https://www.credenceresearch.com/report/controlled-substance-market https://www.credenceresearch.com/report/gamma-aminobutyric-acid-analogs-market Browse Our Blog- https://www.linkedin.com/pulse/antipsoriatics-market-top-players-size-share-analysis-shukla** **About Us-** Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task. **Contact Us:** Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India